Cargando…

P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design

Detalles Bibliográficos
Autores principales: Amri, H, Haramati, A, Abu-Asab, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373347/
http://dx.doi.org/10.1186/1472-6882-12-S1-P115
_version_ 1782235444513079296
author Amri, H
Haramati, A
Abu-Asab, M
author_facet Amri, H
Haramati, A
Abu-Asab, M
author_sort Amri, H
collection PubMed
description
format Online
Article
Text
id pubmed-3373347
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33733472012-06-13 P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design Amri, H Haramati, A Abu-Asab, M BMC Complement Altern Med Poster Presentation BioMed Central 2012-06-12 /pmc/articles/PMC3373347/ http://dx.doi.org/10.1186/1472-6882-12-S1-P115 Text en Copyright ©2012 Amri et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Amri, H
Haramati, A
Abu-Asab, M
P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_full P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_fullStr P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_full_unstemmed P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_short P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design
title_sort p02.59. complexity of disease and population heterogeneity require a rethinking of clinical trial design
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3373347/
http://dx.doi.org/10.1186/1472-6882-12-S1-P115
work_keys_str_mv AT amrih p0259complexityofdiseaseandpopulationheterogeneityrequirearethinkingofclinicaltrialdesign
AT haramatia p0259complexityofdiseaseandpopulationheterogeneityrequirearethinkingofclinicaltrialdesign
AT abuasabm p0259complexityofdiseaseandpopulationheterogeneityrequirearethinkingofclinicaltrialdesign